DOCSLIB.ORG

Usepa: Toxicological Review of Trichloroacetic Acid

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Usepa: Toxicological Review of Trichloroacetic Acid DRAFT - DO NOT CITE OR QUOTE EPA/635/R-09/003A www.epa.gov/iris TOXICOLOGICAL REVIEW OF TRICHLOROACETIC ACID (CAS No. 76-03-9) In Support of Summary Information on the Integrated Risk Information System (IRIS) September 2009 NOTICE This document is an External Review draft. This information is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy. It is being circulated for review of its technical accuracy and science policy implications. U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document is a preliminary draft for review purposes only. This information is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. ii DRAFT - DO NOT CITE OR QUOTE CONTENTS—TOXICOLOGICAL REVIEW OF TRICHLOROACETIC ACID (CAS No. 76-03-9) LIST OF TABLES .......................................................................................................................... v LIST OF FIGURES ....................................................................................................................... vi LIST OF ABBREVIATIONS AND ACRONYMS ..................................................................... viii FOREWORD ................................................................................................................................. xi AUTHORS, CONTRIBUTORS, AND REVIEWERS ................................................................. xii 1. INTRODUCTION ..................................................................................................................... 1 2. CHEMICAL AND PHYSICAL INFORMATION .................................................................... 3 3. TOXICOKINETICS .................................................................................................................. 5 3.1. ABSORPTION ................................................................................................................. 5 3.2. DISTRIBUTION ............................................................................................................... 7 3.3. METABOLISM .............................................................................................................. 11 3.4. EXCRETION .................................................................................................................. 17 3.5. PHYSIOLOGICALLY BASED AND OTHER TOXICOKINETIC MODELS ............ 19 4. HAZARD IDENTIFICATION ................................................................................................ 20 4.1. STUDIES IN HUMANS ................................................................................................. 20 4.1.1. Oral Exposure ..................................................................................................... 20 4.1.2. Dermal Exposure ................................................................................................ 20 4.2. SUBCHRONIC AND CHRONIC STUDIES AND CANCER BIOASSAYS IN ANIMALS―ORAL AND INHALATION ................................................................... 22 4.2.1. Subchronic Studies ............................................................................................. 22 4.2.2. Chronic Studies and Cancer Assays ................................................................... 38 4.3. REPRODUCTIVE AND DEVELOPMENTAL STUDIES ........................................... 57 4.3.1. Reproductive Studies .......................................................................................... 57 4.3.2. Developmental Studies ....................................................................................... 57 4.4. OTHER ENDPOINT-SPECIFIC STUDIES .................................................................. 67 4.4.1. Immunological Studies ....................................................................................... 67 4.5. MECHANISTIC DATA AND OTHER STUDIES IN SUPPORT OF THE MODE OF ACTION ........................................................................................................................ 67 4.5.1. Mechanistic Studies ............................................................................................ 67 4.5.2. Genotoxicity Studies ........................................................................................... 81 4.6. SYNTHESIS OF MAJOR NONCANCER EFFECTS ................................................... 87 4.6.1. Oral ..................................................................................................................... 87 4.6.2. Inhalation ............................................................................................................ 89 4.6.3. Mode-of-Action Information .............................................................................. 90 4.7. EVALUATION OF CARCINOGENICITY ................................................................... 92 4.7.1. Summary of Overall Weight of Evidence ........................................................... 92 4.7.2. Synthesis of Human, Animal, and Other Supporting Evidence.......................... 92 4.7.3. Mode-of-Action Information .............................................................................. 93 4.8. SUSCEPTIBLE POPULATION AND LIFE STAGES ............................................... 115 4.8.1. Possible Childhood Susceptibility .................................................................... 115 4.8.2. Possible Gender Differences ............................................................................. 116 4.8.3. Other Factors Influencing Susceptibility .......................................................... 117 iii DRAFT - DO NOT CITE OR QUOTE 5. DOSE-RESPONSE ASSESSMENTS ................................................................................... 118 5.1. ORAL REFERENCE DOSE (RfD) .............................................................................. 118 5.1.1. Choice of Principal Study and Critical Effect—with Rationale and Justification ...................................................................................................... 118 5.1.2. Methods of Analysis ......................................................................................... 123 5.1.3. RfD Derivation—Including Application of Uncertainty Factors (UFs) ........... 131 5.1.4. RfD Comparison Information ........................................................................... 133 5.1.5. Previous RfD Assessment ................................................................................. 133 5.2. INHALATION REFERENCE CONCENTRATION (RfC) ......................................... 133 5.3. UNCERTAINTIES IN THE ORAL REFERENCE DOSE .......................................... 134 5.4. CANCER ASSESSMENT ............................................................................................ 135 5.4.1. Choice of Study/Data—with Rationale and Justification ................................. 137 5.4.2. Dose-Response Data ......................................................................................... 137 5.4.3. Dose Conversion ............................................................................................... 139 5.4.4. Extrapolation Methods ...................................................................................... 140 5.4.5. Oral Cancer Slope Factor and Inhalation Unit Risk ......................................... 142 5.4.6. Previous Cancer Assessment ............................................................................ 142 6. MAJOR CONCLUSIONS IN THE CHARACTERIZATION OF HAZARD AND DOSE RESPONSE ........................................................................................................................... 143 6.1. HUMAN HAZARD POTENTIAL ............................................................................... 143 6.2. DOSE RESPONSE ....................................................................................................... 146 6.2.1. Noncancer/Oral ................................................................................................. 146 6.2.2. Noncancer/Inhalation ........................................................................................ 147 6.2.3. Cancer/Oral and Inhalation ............................................................................... 147 7. REFERENCES ...................................................................................................................... 149 APPENDIX A. SUMMARY OF EXTERNAL PEER REVIEW AND PUBLIC COMMENTS AND DISPOSITION ............................................................................................................ A-1 APPENDIX B. BENCHMARK DOSE MODELING RESULTS FOR THE INCIDENCE OF HEPATOCELLULAR INFLAMMATION, HEPATOCELLULAR NECROSIS, AND TESTICULAR TUBULAR DEGENERATION IN MICE EXPOSED TO TCA IN DRINKING WATER FOR USE IN DERIVATION OF THE REFERENCE DOSE ......... B-1 APPENDIX C. INPUT AND OUTPUT DATA FOR BENCHMARK DOSE MODELING OF DEVELOPMENTAL DATA FROM SMITH ET AL. (1989) ............................................. C-1 APPENDIX D. MODELING OF LIVER TUMOR INCIDENCE DATA FOR
Load more

Recommended publications
  • Chemical Synthesis, Characterization and Biological Evaluation of Methylation and Glycation Dna Adducts
    University of Rhode Island DigitalCommons@URI Open Access Dissertations 2019 CHEMICAL SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF METHYLATION AND GLYCATION DNA ADDUCTS Qi Tang University of Rhode Island, [email protected] Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss Recommended Citation Tang, Qi, "CHEMICAL SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF METHYLATION AND GLYCATION DNA ADDUCTS" (2019). Open Access Dissertations. Paper 844. https://digitalcommons.uri.edu/oa_diss/844 This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more information, please contact [email protected]. CHEMICAL SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF METHYLATION AND GLYCATION DNA ADDUCTS BY QI TANG A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN PHARMACEUTICAL SCIENCES UNIVERSITY OF RHODE ISLAND 2019 DOCTOR OF PHILOSOPHY DISSERTATION OF QI TANG APPROVED: Dissertation Committee: Major Professor Deyu Li Bongsup Cho Gongqin Sun Nasser H. Zawia DEAN OF THE GRADUATE SCHOOL UNIVERSITY OF RHODE ISLAND 2019 ABSTRACT The integrity of genomic DNA is constantly challenged by endogenous and environmental agents with the formation of DNA adducts. Some of these adducts are toxic and mutagenic to replication, thus potentially leading to cancer and other genetic diseases. To counteract the undesired DNA modifications from damaging agents, cells have evolved a number of repair pathways, such as base-excision repair, nucleotide-excision repair, mismatch repair, and direct reversal repair, to restore the intact DNA. However, DNA repair is not always efficient, there are many interfering factors, such as inherited deficiency in DNA repair pathways, or the abnormal uptake of substance with inhibitory effects to DNA repair enzymes that may result in the accumulation of DNA adducts.
    [Show full text]
  • Chapter 1 Introduction
    The Cytotoxic Effects of Malondialdehyde on Human Lung Fibroblast Cells Sally Ann Yates A thesis submitted in partial fulfilment of the requirements of Liverpool John Moores University for the degree of Doctor of Philosophy March 2015 Abstract ABSTRACT Malondialdehyde (MDA) is a mutagenic and carcinogenic product of lipid peroxidation which has also been found at elevated levels in smokers. MDA reacts with nucleic acid bases to form pyrimidopurinone DNA adducts, of which 3-(2-deoxy-β-D-erythro- pentofuranosyl)pyrimidol[1,2-α]purin-10(3H)-one (M1dG) is the most abundant and has been linked to smoking. Mutations in the TP53 tumour suppressor gene are associated with half of all cancers. This research applied a multidisciplinary approach to investigate the toxic effects of MDA on the human lung fibroblasts MRC5, which have an intact p53 response, and their SV40 transformed counterpart, MRC5 SV2, which have a sequestered p53 response. Both cell lines were treated with MDA (0-1000 µM) for 24 and 48 h and subjected to a variety of analyses to examine cell proliferation, cell viability, cellular and nuclear morphology, apoptosis, p53 protein expression, DNA topography and M1dG adduct detection. For the first time, mutation sequencing of the 5’ untranslated region (UTR) of the TP53 gene in response to MDA treatment was carried out. The main findings were that both cell lines showed reduced proliferation and viability with increasing concentrations of MDA, the cell surface and nuclear morphology were altered, and levels of apoptosis and p53 protein expression appeared to increase. A LC-MS-MS method for detection of M1dG adducts was developed and adducts were detected in CT-DNA treated with MDA in a dose-dependent manner.
    [Show full text]
  • Derived Exocyclic Guanine Adducts by the #-Ketoglutarate/Fe(II) Dioxygenase Alkb
    Mechanism of Repair of Acrolein- and Malondialdehyde- Derived Exocyclic Guanine Adducts by the #-Ketoglutarate/Fe(II) Dioxygenase AlkB The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Singh, Vipender, Bogdan I. Fedeles, Deyu Li, James C. Delaney, Ivan D. Kozekov, Albena Kozekova, Lawrence J. Marnett, Carmelo J. Rizzo, and John M. Essigmann. “Mechanism of Repair of Acrolein- and Malondialdehyde-Derived Exocyclic Guanine Adducts by the α-Ketoglutarate/Fe(II) Dioxygenase AlkB.” Chemical Research in Toxicology 27, no. 9 (September 15, 2014): 1619–1631. © 2014 American Chemical Society As Published http://dx.doi.org/10.1021/tx5002817 Publisher American Chemical Society (ACS) Version Final published version Citable link http://hdl.handle.net/1721.1/99406 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. Article pubs.acs.org/crt Mechanism of Repair of Acrolein- and Malondialdehyde-Derived Exocyclic Guanine Adducts by the α‑Ketoglutarate/Fe(II) Dioxygenase AlkB † ‡ § ⊥ † ‡ § ⊥ † ‡ § ⊥ † ‡ § # ∥ Vipender Singh, , , , Bogdan I. Fedeles, , , , Deyu Li, , , , James C. Delaney, , , , Ivan D. Kozekov, ∥ ∥ ∥ † ‡ § Albena Kozekova, Lawrence J. Marnett, Carmelo J. Rizzo, and
    [Show full text]
  • Redalyc.THEORETICAL STUDY of the MALONDIALDEHYDE
    Vitae ISSN: 0121-4004 [email protected] Universidad de Antioquia Colombia QUIJANO P., Silvia; NOTARIO B., Rafael; QUIJANO T., Jairo; RAMÍREZ A., Luz A.; VÉLEZ O., Ederley; GIL G., Maritza A. THEORETICAL STUDY OF THE MALONDIALDEHYDE-ADDUCTS FORMED BY REACTION WITH DNA-BASES Vitae, vol. 11, núm. 1, 2004, pp. 5-12 Universidad de Antioquia Medellín, Colombia Available in: http://www.redalyc.org/articulo.oa?id=169818259002 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative 5 VITAE, REVISTA DE LA FACULTAD DE QUÍMICA FARMACÉUTICA ISSN 0121-4004 Volumen 11 número 1, año 2004. Universidad de Antioquia, Medellín - Colombia. págs. 5-12 THEORETICAL STUDY OF THE MALONDIALDEHYDE- ADDUCTS FORMED BY REACTION WITH DNA-BASES ESTUDIO TEÓRICO DE LOS ADUCTOS-MALONDIALDEHÍDO FORMADOS POR LA REACCIÓN CON BASES ADN Silvia QUIJANO P.,1* Rafael NOTARIO B.,2 Jairo QUIJANO T.,3 Luz A. RAMÍREZ A.,3 Ederley VÉLEZ O.3 y Maritza A. GIL G.3 ABSTRACT Malondialdehyde (MDA) is a major genotoxic carbonyl compound generated by lipid peroxidation and is also a by-product of the arachidonic acid metabolism in the synthesis of prostaglandins. MDA has been shown to be mutagenic in bacterial and mammalian systems and carcinogenic in rodents. Besides, it is known that MDA reacts with DNA to form adducts with deoxyguanosine, dG, deoxyadenosine, dA, and deoxycytidine, dC: M1G, M1A and M1C, respectively. In this paper we present a density functional theoretical study of the several nucleophilic additions followed by eliminations of MDA with dG, dA, and dC.
    [Show full text]
  • Formation of DNA-Protein Cross-Links Between Γ-Hydroxypropanodeoxyguanosine and Ecori
    Chem. Res. Toxicol. 2008, 21, 1733–1738 1733 Formation of DNA-Protein Cross-Links Between γ-Hydroxypropanodeoxyguanosine and EcoRI Laurie A. VanderVeen,†,‡ Thomas M. Harris,§ Linda Jen-Jacobson,| and Lawrence J. Marnett*,†,§ A. B. Hancock Jr. Memorial Laboratory for Cancer Research, Departments of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt-Ingram ComprehensiVe Cancer Center, Vanderbilt UniVersity School of Medicine, NashVille, Tennessee 37232, and Department of Biological Sciences, UniVersity of Pittsburgh, Pittsburgh, PennsylVania 15260 ReceiVed March 8, 2008 The toxicity of acrolein, an R,-unsaturated aldehyde produced during lipid peroxidation, is attributable to its high reactivity toward DNA and cellular proteins. The major acrolein-DNA adduct, γ-hydrox- ypropano-2′-deoxyguanosine (γ-HOPdG), ring opens to form a reactive N2-oxopropyl moiety that cross- links to DNA and proteins. We demonstrate the ability of γ-HOPdG in a duplex oligonucleotide to cross- link to a protein (EcoRI) that specifically interacts with DNA at a unique sequence. The formation of a cross-link to EcoRI was dependent on the intimate binding of the enzyme to its γ-HOPdG-modified recognition site. Interestingly, the cross-link did not restrict the ability of EcoRI to cleave DNA substrates. However, stabilization of the cross-link by reduction of the Schiff base linkage resulted in loss of enzyme activity. This work indicates that the γ-HOPdG-EcoRI cross-link is in equilibrium with free oligonucleotide and enzyme. Reversal of cross-link formation allows EcoRI to effect enzymatic cleavage of competitor oligonucleotides. Introduction Noncovalent interactions between DNA and proteins are essential for proper cellular function.
    [Show full text]
  • Quantitative Analysis of Malondialdehyde-Guanine Adducts in Genomic DNA Samples by Liquid Chromatography Tandem Mass Spectrometry
    Quantitative analysis of malondialdehyde-guanine adducts in genomic DNA samples by liquid chromatography tandem mass spectrometry S. A. Yates, N. M. Dempster, M. F. Murphy and S. A. Moore* School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK *Corresponding author. E-mail: [email protected] Abstract RATIONALE The lipid peroxidation product malondialdehyde forms M1dG adducts with guanine bases in genomic DNA. The analysis of these adducts is important as a biomarker of lipid peroxidation, oxidative stress and inflammation which may be linked to disease risk or exposure to a range of chemicals. METHODS Genomic DNA samples were subjected to acid hydrolysis to release the adducts in the base form (M1G) alongside the other purines. A liquid chromatography-mass spectrometry method was optimised for the quantitation of the M1G adducts in genomic DNA samples using product ion and multiple reaction mode scans. RESULTS Product ion scans revealed four product ions from the precursor ion; m/z 188 → 160, 133, 106 and 79. The two smallest ions have not been observed previously and optimisation of the method revealed that these gave better sensitivity (LOQ m/z 79: 162 adducts per 107 nucleotides; m/z 106: 147 adducts per 107 nucleotides) than the other two ions. An MRM method gave similar sensitivity but the two smallest product ions gave better accuracy (94-95%). Genomic DNA treated with malondialdehyde showed a linear dose-response relationship. CONCLUSION A fast reliable sample preparation method was used to release adducts in the base form rather than the nucleoside. The methods were optimised to selectively analyse the adducts in the presence of other DNA bases without the need for further sample clean-up.
    [Show full text]
  • Molecular Aspects of Mycotoxins—A Serious Problem for Human Health
    International Journal of Molecular Sciences Review Molecular Aspects of Mycotoxins—A Serious Problem for Human Health Edyta Janik 1 , Marcin Niemcewicz 1, Michal Ceremuga 2, Maksymilian Stela 3, Joanna Saluk-Bijak 4, Adrian Siadkowski 5 and Michal Bijak 1,* 1 Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland; [email protected] (E.J.); [email protected] (M.N.) 2 Military Institute of Armament Technology, Prymasa Stefana Wyszy´nskiego7, 05-220 Zielonka, Poland; [email protected] 3 CBRN Reconnaissance and Decontamination Department, Military Institute of Chemistry and Radiometry, Antoniego Chrusciela “Montera” 105, 00-910 Warsaw, Poland; [email protected] 4 Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland; [email protected] 5 Department of Security and Crisis Menagement, Faculty of Applied Sciences, University of Dabrowa Gornicza, Zygmunta Cieplaka 1c, 41-300 Dabrowa Gornicza, Poland; [email protected] * Correspondence: [email protected]; Tel./Fax: +48-(42)-635-43-36 Received: 17 September 2020; Accepted: 30 October 2020; Published: 31 October 2020 Abstract: Mycotoxins are toxic fungal secondary metabolities formed by a variety of fungi (moulds) species. Hundreds of potentially toxic mycotoxins have been already identified and are considered a serious problem in agriculture, animal husbandry, and public health. A large number of food-related products and beverages are yearly contaminated by mycotoxins, resulting in economic welfare losses. Mycotoxin indoor environment contamination is a global problem especially in less technologically developed countries.
    [Show full text]
  • DNA Damage by Lipid Peroxidation Products: Implications in Cancer, Inflammation and Autoimmunity
    Published online: 2021-05-10 AIMS Genetics, 4(2): 103-137. DOI: 10.3934/genet.2017.2.103 Received: 14 December 2016 Accepted: 12 April 2017 Published: 18 April 2017 http://www.aimspress.com/journal/Genetics Review DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity Fabrizio Gentile1, Alessia Arcaro1, Stefania Pizzimenti2, Martina Daga2, Giovanni Paolo Cetrangolo1, Chiara Dianzani3, Alessio Lepore4, Maria Graf4, Paul R. J. Ames5 and Giuseppina Barrera2,* 1 Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Campobasso, Italy 2 Department of Clinical and Biological Sciences, University of Torino, Torino, Italy 3 Department of Drug Science and Technology, University of Torino, Torino, Italy 4 Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy 5 CEDOC, NOVA Medical School, Universidade NOVA de Lisboa, Lisboa, Portugal, and Department of Haematology, Dumfries Royal Infirmary, Dumfries, Scotland, UK * Correspondence: Email: [email protected]; Tel: +39-011-6707795. Abstract: Oxidative stress and lipid peroxidation (LPO) induced by inflammation, excess metal storage and excess caloric intake cause generalized DNA damage, producing genotoxic and mutagenic effects. The consequent deregulation of cell homeostasis is implicated in the pathogenesis of a number of malignancies and degenerative diseases. Reactive aldehydes produced by LPO, such as malondialdehyde, acrolein, crotonaldehyde and 4-hydroxy-2-nonenal, react with DNA bases, generating promutagenic exocyclic DNA adducts, which likely contribute to the mutagenic and carcinogenic effects associated with oxidative stress-induced LPO. However, reactive aldehydes, when added to tumor cells, can exert an anticancerous effect. They act, analogously to other chemotherapeutic drugs, by forming DNA adducts and, in this way, they drive the tumor cells toward apoptosis.
    [Show full text]
  • Mutagenicity in Escherichia Coli of the Major DNA Adduct Derived from The
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 8652–8657, August 1997 Genetics Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde (pyrimido[1,2-a]purin-10(3H)-oneysite-specific mutagenesisynucleotide excision repairytemplate utilization) STEPHEN P. FINK,G.RAMACHANDRA REDDY*, AND LAWRENCE J. MARNETT† A. B. Hancock, Jr. Memorial Laboratory for Cancer, Department of Biochemistry, Center in Molecular Toxicology and The Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232-0146 Communicated by Gerald N. Wogan, Massachusetts Institute of Technology, Cambridge, MA, June 6, 1997 (received for review February 19, 1997) ABSTRACT The spectrum of mutations induced by the reaction of malondialdehyde (MDA) with deoxyguanosine naturally occurring DNA adduct pyrimido[1,2-a]purin- residues in DNA. MDA is a product of lipid peroxidation and 10(3H)-one (M1G) was determined by site-specific approaches eicosanoid biosynthesis, and it is widely generated in human using M13 vectors replicated in Escherichia coli.M1G was tissues (20). It is mutagenic to bacterial and mammalian cells placed at position 6256 in the (2)-strand of M13MB102 by and is carcinogenic in animal studies (21–25). Thus, it is ligating the oligodeoxynucleotide 5*-GGT(M1G)TCCG-3* into important to determine the biological activity of MDA–DNA a gapped-duplex derivative of the vector. Unmodified and adducts, especially M1G, which is detectable in healthy human M1G-modified genomes containing either a cytosine or thy- beings. mine at position 6256 of the (1)-strand were transformed into Attempts to evaluate the mutagenic potential of M1G have repair-proficient and repair-deficient E.
    [Show full text]
  • Review Article Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
    Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2014, Article ID 360438, 31 pages http://dx.doi.org/10.1155/2014/360438 Review Article Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal Antonio Ayala, Mario F. Muñoz, and Sandro Argüelles Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Seville, Prof Garc´ıa Gonzales s/n., 41012 Seville, Spain Correspondence should be addressed to Sandro Arguelles;¨ [email protected] Received 14 February 2014; Accepted 24 March 2014; Published 8 May 2014 AcademicEditor:KotaV.Ramana Copyright © 2014 Antonio Ayala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Lipid peroxidation can be described generally as a process under which oxidants such as free radicals attack lipids containing carbon-carbon double bond(s), especially polyunsaturated fatty acids (PUFAs). Over the last four decades, an extensive body of literature regarding lipid peroxidation has shown its important role in cell biology and human health. Since the early 1970s, the total published research articles on the topic of lipid peroxidation was 98 (1970–1974) and has been increasing at almost 135-fold, by up to 13165 in last 4 years (2010–2013). New discoveries about the involvement in cellular physiology and pathology, as well as the control
    [Show full text]
  • Methods of DNA Adduct Determination and Their Application to Testing Compounds for Genotoxicity
    Environmental and Molecular Mutagenesis 35:222Ð233 (2000) Methods of DNA Adduct Determination and Their Application to Testing Compounds for Genotoxicity D. H. Phillips,1* P. B. Farmer,2 F. A. Beland,3 R. G. Nath,4 M. C. Poirier,5 M. V. Reddy,6 and K. W. Turteltaub7 1Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom 2MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, United Kingdom 3National Center for Toxicological Research, Division of Biochemical Toxicology, Jefferson, Arkansas 4Covance Laboratories Inc., Genetic and Cellular Toxicology, Vienna, Virginia 5National Cancer Institute, Bethesda, Maryland 6Merck Research Laboratories, West Point, Pennsylvania 7Lawrence Livermore National Laboratory, Biology & Biotechnology Research Program, Livermore, California At the International Workshop on Genotoxicity Test labeling analysis of the DNA, or by physicochem- Procedures (IWGTP) held in Washington, DC ical methods including mass spectrometry, fluores- (March 25–26, 1999), a working group consid- cence spectroscopy, or electrochemical detection, ered the uses of DNA adduct determination meth- or by immunochemical methods. Each of these ods for testing compounds for genotoxicity. When approaches has different strengths and limitations, a drug or chemical displays an unusual or incon- influenced by sensitivity, cost, time, and interpreta- sistent combination of positive and negative results tion of results. The design of DNA binding studies in in vitro and in vivo genotoxicity assays and/or needs to be on a case-by-case basis, depending on in carcinogenicity experiments, investigations into the compound’s profile of activity. DNA purity be- whether or not DNA adducts are formed may be comes increasingly important the more sensitive, helpful in assessing whether or not the test com- and less chemically specific, the assay.
    [Show full text]